CCM
SPPI

Cadence Capital Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Cadence Capital Management’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-64,830
Closed -$412K – 668
2016
Q1 		$412K Buy
+64,830
New +$333K 0.03% 505

Other funds holding SPPI

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Cadence Capital Management's SPPI Position: Q2 2016 in Review

Cadence Capital Management sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q2 2016, closing a stake of 64,830 shares — an estimated $412K sold.

Cadence Capital Management first reported a position in SPPI in Q1 2016 and held it in 1 quarter. The position peaked at $412K in Q1 2016. 161 funds tracked by Wall St. Rank hold SPPI as of Q2 2016.

  • Cadence Capital Management reported no remaining Spectrum Pharmaceuticals Inc position as of Q2 2016 after selling out during the quarter.
  • Cadence Capital Management sold 64,830 Spectrum Pharmaceuticals Inc shares in Q2 2016, an estimated $412K.
  • Cadence Capital Management first reported a position in Spectrum Pharmaceuticals Inc in Q1 2016 and held it in 1 quarter.
  • Cadence Capital Management's Spectrum Pharmaceuticals Inc position peaked at $412K in Q1 2016.
  • 161 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q2 2016.

Based on Cadence Capital Management's 13F filing for Q2 2016, filed 3 Aug 2016.